Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!

被引:12
作者
Andre, Pascal [1 ]
Diezi, Leonore [1 ]
Dao, Kim [1 ]
Crisinel, Pierre Alex [2 ]
Rothuizen, Laura E. [1 ]
Chtioui, Haithem [1 ]
Decosterd, Laurent Arthur [1 ]
Diezi, Manuel [3 ]
Asner, Sandra [2 ]
Buclin, Thierry [1 ]
机构
[1] Univ Lausanne, Univ Hosp Ctr, Serv Clin Pharmacol, Lausanne, Switzerland
[2] Univ Lausanne, Univ Hosp Ctr, Serv Pediat, Pediat Infect Dis & Vaccinol Unit, Lausanne, Switzerland
[3] Univ Lausanne, Univ Hosp Ctr, Serv Pediat, Pediat Hematooncol Unit, Lausanne, Switzerland
关键词
meropenem; piperacillin; beta-lactams; child; neoplasms; cancer; kidney function tests; augmented renal clearance; ACUTE LYMPHOBLASTIC-LEUKEMIA; GLOMERULAR-FILTRATION RATE; CANCER; PIPERACILLIN; MORTALITY; EXPOSURE; DEATHS;
D O I
10.3389/fped.2021.768438
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: Broad-spectrum beta-lactams are commonly prescribed for empirical or selective treatment of bacterial infections in children with malignancies. In the immunocompromised, appropriate concentration exposure is crucial to ensure antimicrobial efficacy. Augmented renal clearance (ARC) is increasingly recognized in this population, and raises concern for unmet concentration targets. We conducted a retrospective evaluation of meropenem and piperacillin exposure in our hospital's pediatric hematology-oncology patients.Materials and Methods: We compared trough levels of meropenem and piperacillin in a cohort of unselected pediatric hematology-oncology patients stratified based on their estimated renal function as decreased, normal or with ARC, and on their neutrophil count.Results: Thirty-two children provided a total of 51 meropenem and 76 piperacillin samples. On standard intermittent intravenous regimen, 67% of all trough plasma concentrations were below targeted concentrations. In neutropenic children with bacterial infection, all meropenem and 60% of piperacillin levels were below target. Nearly two-thirds of total samples came from children with ARC. In these patients, antimicrobial exposure was insufficient in 85% of cases (compared to 36% in the decreased or normal renal function groups), despite a dosage sometimes exceeding the maximum recommended daily dose. Under continuous infusion of piperacillin, only 8% of plasma levels were insufficient.Discussion: Intermittent administration of meropenem and piperacillin often fails to ensure sufficient concentration exposure in children treated for malignancies, even at maximal recommended daily dosage. This can in part be attributed to ARC. We recommend thorough assessment of renal function, resolute dosage adjustment, continuous infusion whenever possible and systematic therapeutic drug monitoring.
引用
收藏
页数:9
相关论文
共 47 条
[1]   Infections in children with cancer: A continued need for the comprehensive physical examination [J].
Auletta, JJ ;
O'Riordan, MA ;
Nieder, ML .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (06) :501-508
[2]   Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? [J].
Carlier, Mieke ;
Carrette, Sofie ;
Roberts, Jason A. ;
Stove, Veronique ;
Verstraete, Alain ;
Hoste, Eric ;
Depuydt, Pieter ;
Decruyenaere, Johan ;
Lipman, Jeffrey ;
Wallis, Steven C. ;
De Waele, Jan J. .
CRITICAL CARE, 2013, 17 (03)
[3]   Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study [J].
Carrie, Cedric ;
Petit, Laurent ;
d'Houdain, Nicolas ;
Sauvage, Noemie ;
Cottenceau, Vincent ;
Lafitte, Melanie ;
Foumenteze, Cecile ;
Hisz, Quentin ;
Menu, Deborah ;
Legeron, Rachel ;
Breilh, Dominique ;
Sztark, Francois .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (03) :443-449
[4]   Bacteremia in childhood cancer [J].
Celkan, T ;
Ozkan, A ;
Apak, H ;
Diren, S ;
Can, G ;
Yuksel, L ;
Yildiz, I .
JOURNAL OF TROPICAL PEDIATRICS, 2002, 48 (06) :373-377
[5]   Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries:: 1992-2001 [J].
Christensen, MS ;
Heyman, M ;
Möttönen, M ;
Zeller, B ;
Jonmundsson, G ;
Hasle, H .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (01) :50-58
[6]   Recent Advances in Stability Studies of Carbapenems [J].
Cielecka-Piontek, Judyta ;
Michalska, Katarzyna ;
Zalewski, Przemyslaw ;
Jelinska, Anna .
CURRENT PHARMACEUTICAL ANALYSIS, 2011, 7 (04) :213-227
[7]   Population Pharmacokinetics of Continuous-Infusion Meropenem in Febrile Neutropenic Patients with Hematologic Malignancies: Dosing Strategies for Optimizing Empirical Treatment against Enterobacterales and P. aeruginosa [J].
Cojutti, Pier Giorgio ;
Candoni, Anna ;
Lazzarotto, Davide ;
Fili, Carla ;
Zannier, Maria ;
Fanin, Renato ;
Pea, Federico .
PHARMACEUTICS, 2020, 12 (09) :1-11
[8]   Augmented Renal Clearance [J].
Cook, Aaron M. ;
Hatton-Kolpek, Jimmi .
PHARMACOTHERAPY, 2019, 39 (03) :346-354
[9]   Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: Analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98 [J].
Creutzig, U ;
Zimmermann, M ;
Reinhardt, D ;
Dworzak, M ;
Stary, J ;
Lehrnbecher, T .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) :4384-4393
[10]   Augmented Renal Vancomycin Clearance in Cancer Patients: A Case Report and Review of the Literature [J].
Curth, Harald-Morten ;
Pelc, Agnes ;
Kuetting, Fabian ;
Steffen, Hans-Michael .
ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (04) :182-184